Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3040 (LINC03040)
- Target
- LINC03040
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Non-coding RNA (ncRNA)
01
Overview
LINC03040 is a human long intergenic non-protein coding RNA gene (lincRNA) mapped to chromosome 6p21.1. It comprises four transcript variants and does not encode a protein, making it a member of the non-coding RNA family. LINC03040 is relatively more expressed in lung tissue, but its biological roles remain largely uncharacterized. lincRNAs contribute regulatory functions in many contexts, such as transcriptional modulation, chromatin remodeling, cellular signaling, and disease; however, these specific activities have not been experimentally confirmed for LINC03040. It is not currently recognized as a therapeutic target, pathway component, or biomarker
- Other names
- C6orf223MGC45491Uncharacterized protein LINC03040Uncharacterized protein C6orf223LINC03040
02
Mechanism of action
None (no mechanisms of action for targeted drugs; LINC03040 is not a defined pharmacological target)
03
Biological functions
Other (specific functions, if any, are currently unknown; in general, lincRNAs can modulate chromatin, regulate transcription, scaffold proteins, or participate in RNA stabilization, but these roles have not been specifically attributed to LINC03040)
04
Disease associations
Other (no definitive disease association is established; in general, lincRNAs may have roles in cancer, immune response, and complex disorders, but LINC03040’s contribution has not been specifically elucidated)
05
Safety considerations
None (no notable safety concerns or therapeutic challenges reported; general safety considerations for manipulating lincRNAs in therapy are theoretical and not specific to LINC03040)
06
Interacting drugs
None (no drugs are reported to interact with LINC03040 in the literature or databases)
07
Biomarkers
None (LINC03040 is not currently in use or proposed as a biomarker for patient selection or efficacy monitoring)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 3040 (LINC03040).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3040 (LINC03040).